会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Method and apparatus for correlating levels of biomarker products with disease
    • 将生物标记产物与疾病相关的方法和装置
    • US20070213939A1
    • 2007-09-13
    • US11585666
    • 2006-10-23
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • G06F19/00
    • C12Q1/6886C12Q2600/112C12Q2600/136C12Q2600/158C12Q2600/16G06F19/12G06F19/18G06F19/20G06F19/24G16H50/30Y02A90/26
    • In one aspect the invention is a method of testing for one or more colorectal pathologies or one or more subtypes of colorectal pathology (in one embodiment colorectal cancer) in a test individual by providing data corresponding to a level of products of selected biomarkers and applying the data to a formula to provide an indication of whether the test individual has one or more colorectal pathologies or one or more subtypes of colorectal pathology. In some aspects the method is computer based and a computer applies the data to the formula. In other aspects a computer system is configured with instructions that cause the processor to provide a user with the indication of whether the test individual has colorectal pathology. Also encompassed are kits for measuring data corresponding to the products of selected biomarkers which in some embodiments include a computer readable medium. Also encompassed are kits and methods of monitoring therapeutic efficacy of treatments for one or more colorectal pathologies.
    • 在一个方面,本发明是通过提供对应于所选生物标志物的产物水平的数据并应用所述生物标志物的一个或多个结直肠病理学或一种或多种结直肠病理学亚型(在一个实施方案中为结肠直肠癌)的测试个体中的方法, 数据提供给公式,以提供测试个体是否具有一种或多种结肠直肠病变或一种或多种结直肠病理学亚型的指示。 在某些方面,该方法是基于计算机的,并且计算机将数据应用于公式。 在其他方面,计算机系统配置有指令,其使得处理器向用户提供测试个体是否具有结肠直肠病理学的指示。 还包括用于测量与所选生物标志物的产物相对应的数据的试剂盒,其在一些实施方案中包括计算机可读介质。 还包括监测一种或多种结肠直肠病变治疗效果的试剂盒和方法。
    • 3. 发明申请
    • Method and Apparatus for Correlating Levels of Biomarker Products with Disease
    • 将生物标志物产品与疾病相关联的方法和装置
    • US20090208942A1
    • 2009-08-20
    • US12091049
    • 2006-10-23
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • C12Q1/68G06G7/48
    • C12Q1/6886C12Q2600/112C12Q2600/136C12Q2600/158C12Q2600/16G06F19/12G06F19/18G06F19/20G06F19/24G16H50/30Y02A90/26
    • In one aspect the invention is a method of testing for one or more colorectal pathologies or one or more subtypes of colorectal pathology (in one embodiment colorectal cancer) in a test individual by providing data corresponding to a level of products of selected biomarkers and applying the data to a formula to provide an indication of whether the test individual has one or more colorectal pathologies or one or more subtypes of colorectal pathology. In some aspects the method is computer based and a computer applies the data to the formula. In other aspects a computer system is configured with instructions that cause the processor to provide a user with the indication of whether the test individual has colorectal pathology. Also encompassed are kits for measuring data corresponding to the products of selected biomarkers which in some embodiments include a computer readable medium. Also encompassed are kits and methods of monitoring therapeutic efficacy of treatments for one or more colorectal pathologies.
    • 在一个方面,本发明是通过提供对应于所选生物标志物的产物水平的数据并应用所述生物标记物的一个或多个结直肠病理学或一种或多种结直肠病理学(在一个实施方案中为结肠直肠癌)亚型的方法, 数据提供给公式,以提供测试个体是否具有一种或多种结肠直肠病变或一种或多种结直肠病理学亚型的指示。 在某些方面,该方法是基于计算机的,并且计算机将数据应用于公式。 在其他方面,计算机系统配置有指令,其使得处理器向用户提供测试个体是否具有结肠直肠病理学的指示。 还包括用于测量与所选生物标志物的产物相对应的数据的试剂盒,其在一些实施方案中包括计算机可读介质。 还包括监测一种或多种结肠直肠病变治疗效果的试剂盒和方法。
    • 5. 发明授权
    • Method, computer system and computer-readable medium for determining a probability of colorectal cancer in a test subject
    • 用于确定测试对象中结肠直肠癌概率的方法,计算机系统和计算机可读介质
    • US08239136B2
    • 2012-08-07
    • US11585666
    • 2006-10-23
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • Choong-Chin LiewMark HanThomas YagerSamuel ChaoRun ZhengHongwei Zhang
    • G01N33/48
    • C12Q1/6886C12Q2600/112C12Q2600/136C12Q2600/158C12Q2600/16G06F19/12G06F19/18G06F19/20G06F19/24G16H50/30Y02A90/26
    • In one aspect the invention is a method of testing for one or more colorectal pathologies or one or more subtypes of colorectal pathology (in one embodiment colorectal cancer) in a test individual by providing data corresponding to a level of products of selected biomarkers and applying the data to a formula to provide an indication of whether the test individual has one or more colorectal pathologies or one or more subtypes of colorectal pathology. In some aspects the method is computer based and a computer applies the data to the formula. In other aspects a computer system is configured with instructions that cause the processor to provide a user with the indication of whether the test individual has colorectal pathology. Also encompassed are kits for measuring data corresponding to the products of selected biomarkers which in some embodiments include a computer readable medium. Also encompassed are kits and methods of monitoring therapeutic efficacy of treatments for one or more colorectal pathologies.
    • 在一个方面,本发明是通过提供对应于所选生物标志物的产物水平的数据并应用所述生物标记物的一个或多个结直肠病理学或一种或多种结直肠病理学(在一个实施方案中为结肠直肠癌)亚型的方法, 数据提供给公式,以提供测试个体是否具有一种或多种结肠直肠病变或一种或多种结直肠病理学亚型的指示。 在某些方面,该方法是基于计算机的,并且计算机将数据应用于公式。 在其他方面,计算机系统配置有指令,其使得处理器向用户提供测试个体是否具有结肠直肠病理学的指示。 还包括用于测量与所选生物标志物的产物相对应的数据的试剂盒,其在一些实施方案中包括计算机可读介质。 还包括监测一种或多种结肠直肠病变治疗效果的试剂盒和方法。
    • 6. 发明申请
    • Bladder cancer biomarkers and uses thereof
    • 膀胱癌生物标志物及其用途
    • US20070134681A1
    • 2007-06-14
    • US11417354
    • 2006-05-02
    • Choong-Chin LiewMark HanTom YagerSamuel ChaoRun Zheng
    • Choong-Chin LiewMark HanTom YagerSamuel ChaoRun Zheng
    • C12Q1/68
    • G01N33/57407C12Q1/6886C12Q2600/136C12Q2600/158
    • The invention relates to the identification and selection of novel biomarkers and the identification and selection of novel biomarker combinations which are differentially expressed in individuals with bladder cancer as compared with individuals without bladder cancer. Polynucleotides and proteins which specifically and/or selectively hybridize to the products of the biomarkers of the invention are also encompassed within the scope of the invention as are kits containing said polynucleotides and proteins for use in diagnosing bladder cancer. Further encompassed by the invention is the use of the polynucleotides and proteins which specifically and/or selectively hybridize to the product of the biomarkers of the invention to monitor disease regression in an individual and to monitor the efficacy of therapeutic regimens. The invention also provides for methods of using the products of the biomarkers of the invention in the identification of novel therapeutic targets for bladder cancer.
    • 本发明涉及鉴定和选择新型生物标志物,并鉴定和选择与膀胱癌患者相比差异表达的新型生物标志物组合。 与本发明的生物标志物的产物特异性和/或选择性杂交的多核苷酸和蛋白质也包括在本发明的范围内,如含有用于诊断膀胱癌的所述多核苷酸和蛋白质的试剂盒。 本发明进一步包括使用与本发明的生物标志物的产物特异性和/或选择性杂交的多核苷酸和蛋白质,以监测个体的疾病回归并监测治疗方案的功效。 本发明还提供了使用本发明的生物标志物的产物鉴定膀胱癌的新型治疗靶标的方法。